AssuredPartners Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
808
+66
+9% +$24.5K 0.03% 334
2026
Q1
$225K Buy
742
+47
+7% +$15.4K 0.02% 365
2025
Q4
$244K Buy
+695
New +$235K 0.04% 302
2025
Q2
– Sell
-1,110
Closed -$483K – 273
2025
Q1
$483K Buy
1,110
+23
+2% +$9.23K 0.09% 203
2024
Q4
$401K Buy
+1,087
New +$455K 0.08% 224

Other funds holding ELV

AssuredPartners Investment Advisors's ELV Position: Q2 2026 in Review

AssuredPartners Investment Advisors increased its Elevance Health (ELV) stake by 8.9% in Q2 2026, buying an estimated $24.5K and bringing the position to 808 shares worth $312K. The position accounts for 0.03% of the portfolio, ranked #334.

AssuredPartners Investment Advisors first reported a position in ELV in Q4 2024 and has held it in 5 quarters since. The position peaked at $483K in Q1 2025. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • AssuredPartners Investment Advisors held 808 shares of Elevance Health worth $312K as of Q2 2026.
  • AssuredPartners Investment Advisors bought 66 Elevance Health shares in Q2 2026, an estimated $24.5K.
  • Elevance Health made up 0.03% of AssuredPartners Investment Advisors's portfolio in Q2 2026, its #334 holding.
  • AssuredPartners Investment Advisors first reported a position in Elevance Health in Q4 2024 and has held it in 5 quarters since.
  • AssuredPartners Investment Advisors's Elevance Health position peaked at $483K in Q1 2025.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.